Add like
Add dislike
Add to saved papers

Triazine-based covalent organic frameworks for photodynamic inactivation of bacteria as type-II photosensitizers.

With the increase of antibiotic resistances in microorganisms, photodynamic inactivation (PDI) as a clinically proven antibacterial therapy is gaining increasing attention in recent years due to its high efficacy. Herein, we reported two covalent organic frameworks (COFs) materials, namely COFs-Trif-Benz and COF-SDU1, as effective type-II photosensitizers for photodynamic inactivation of bacteria. COFs-Trif-Benz and COF-SDU1 are synthesized through a facile solvothermal reaction between tri-(4-formacylphenoxy)-1,3,5-triazine (trif) and benzidine or p-phenylenediamine with high yield. Their highly ordered and porous structures were confirmed by Fourier transform infrared (FT-IR) spectra, solid state (13)C CP/MAS NMR spectrum, powder X-ray diffraction (PXRD) and Brunauer-Emmett-Teller (BET) analyses. The electronic absorption spectra and electrochemical experiments revealed that the extensive π-conjugation over COFs-Trif-Benz and COF-SDU1 greatly enhance their absorbance capability for visible light and make them have a lower band gap. The photocatalytic antibacterial assay was studied against both Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli O86:B7 (E. coli O86) bacteria. Two materials can kill more than 90% bacteria at concentrations of 100μgmL(-1) after 60-90min of illumination. Thus, both COFs are effective photosensitizers. Mechanism investigation revealed the antibacterial characteristics of the COFs-Trif-Benz and COF-SDU1 can generate reactive oxygen species (ROS) by energy transfer to molecular oxygen ((3)O2) to produce a highly reactive singlet oxygen ((1)O2). Hence, the two materials during the photodynamic were mainly via mechanism type II.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app